Cognetivity Neurosciences Ltd. Share Price

Stocks

CGNS.F

CA19243C1005

Advanced Medical Equipment & Technology

OTC Markets Traded
Market Closed - 17:19:29 25/06/2026 BST 5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for Cognetivity Neurosciences Ltd. -.--% -

Valuation: Cognetivity Neurosciences Ltd.

Market Cap 1.2M 870K 745K 695K 638K 83.26M 1.22M 8.25M 3.21M 41.73M 3.27M 3.2M 138M P/E 2022
-2.9x
P/E 2023 -2.8x
Enterprise Value 245K 178K 152K 142K 130K 17.03M 250K 1.69M 658K 8.54M 668K 654K 28.26M EV / Sales 2022
-
EV / Sales 2023 437,922,999x
Free-Float
85.56%
Yield 2022 *
-
Yield 2023 -
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.14
5 years 0
Extreme 1.0E-6
0.7
10 years 0
Extreme 1.0E-6
1.12
Manager TitleAgeSince
Chief Executive Officer 45 31/03/2013
Compliance Officer 67 20/12/2017
Director TitleAgeSince
Director/Board Member 45 31/12/2016
Director/Board Member 67 20/12/2017
Date Insider Type Main position Quantity % Market Cap.
15/04/24 Option

Founder

600,000 0.6697%
15/04/24 Option

Founder

600,000 0.6697%
23/06/23 Sell

Founder

1,108,160 1.3030%
Change 5-day change 1-year change 3-year change Capi.($)
-99.00%-.--% - - 93
-0.19%-0.84%-11.79%+33.99% 40.77B
-2.83%+12.05%-34.70%+181.67% 14.79B
-1.67%+1.22%-20.40%+71.20% 5.84B
+2.79%+50.92%+59.67% - 3.96B
-5.77%+6.39% - - 2.18B
-2.55%-5.69%+11.81%-39.29% 1.66B
+11.58%+22.69%-26.32% - 1.1B
-4.22%+4.15%+36.68%+131.55% 985M
-1.60%-3.46%+597.73%+890.32% 789M
Average -10.33%+6.64%+76.58%+211.58% 7.21B
Weighted average by Cap. -0.78%+4.61%-5.41%+81.06%

Financials

2022 2023
Net sales - 0.05 0.03 0.03 0.03 0.02 3.15 0.05 0.31 0.12 1.58 0.12 0.12 5.23
Net income -13.13M -9.53M -8.16M -7.61M -6.99M -912M -13.39M -90.32M -35.21M -457M -35.79M -35.01M -1.51B -7.43M -5.4M -4.62M -4.31M -3.96M -516M -7.58M -51.15M -19.94M -259M -20.26M -19.82M -857M
Net Debt -82.43K -59.85K -51.24K -47.81K -43.87K -5.73M -84.05K -567K -221K -2.87M -225K -220K -9.5M -953K -692K -593K -553K -507K -66.23M -972K -6.56M -2.56M -33.19M -2.6M -2.54M -110M
Logo Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Employees
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGNS.F Stock